Comparing the Modified History, Electrocardiogram, Age, Risk Factors, and Troponin Score and Coronary Artery Disease

Getu Teressa1, Varun Bhasin1, Pamela Noack2

  • 1From the Department of Internal Medicine, Stony Brook Medicine, Stony Brook, NY.

Insights

The clinical coronary artery disease consortium (CADC) model better predicts obstructive coronary artery disease (CAD) than the HEART score. Both models effectively identify low-risk patients with minimal 30-day adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Risk Stratification

Background:

  • Accurate prediction of obstructive coronary artery disease (CAD) is crucial for managing patients with acute chest pain.
  • Existing risk assessment tools, such as the History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) score, require validation against newer models.

Purpose of the Study:

  • To compare the predictive performance of the HEART score and the clinical coronary artery disease consortium (CADC) model.
  • To evaluate their ability to identify obstructive CAD and predict 30-day major adverse cardiovascular events (MACE).

Main Methods:

  • A study of 1981 patients with no known CAD presenting with acute chest pain and negative initial troponin/ECG.
  • Classification of chest pain (typical, atypical, nonanginal) for the HEART score's history component.
  • Comparison of C-statistics for predicting obstructive CAD and 30-day MACE using both models.

Main Results:

  • The CADC model demonstrated a higher C-statistic for predicting obstructive CAD (0.792 vs. 0.747, P=0.0005).
  • Both models showed similar performance in predicting 30-day MACE (C-statistics 0.850 for CADC vs. 0.820 for HEART, P=0.11).
  • Both models effectively identified low-risk patients, with <1% 30-day MACE observed in patients predicted as low-risk by either score.

Conclusions:

  • The CADC model is superior to the HEART score in predicting obstructive CAD.
  • Both the HEART score and CADC model are effective in safely stratifying low-risk patients, minimizing 30-day MACE.
  • These findings support the use of the CADC model for enhanced diagnostic accuracy in suspected CAD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
601
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
327